Anat Guz‐Mark

Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn’s Disease Compared With Reactive Monitoring

Amit Assa, Manar Matar, Dan Turner et al. · Gastroenterology · 2019 · 245 citations

Autoimmune Disease, Increased Clinical Remission, Gastroenterology +7

Premature Thelarche: Age at Presentation Affects Clinical Course but Not Clinical Characteristics or Risk to Progress to Precocious Puberty

Liat de Vries, Anat Guz‐Mark, Liora Lazar et al. · The Journal of Pediatrics · 2009 · 75 citations

Adolescent Medicine, Puberty, Adolescence +7

Combination Therapy of Adalimumab With an Immunomodulator Is Not More Effective Than Adalimumab Monotherapy in Children With Crohn’s Disease: A Post Hoc Analysis of the PAILOT Randomized Controlled Trial

Manar Matar, Raanan Shamir, Dan Turner et al. · Inflammatory Bowel Diseases · 2019 · 36 citations · Full text

Chronic Intestinal Failure in Children: An International Multicenter Cross-Sectional Survey

Antonella Lezo, Antonella Diamanti, Evelyne Marinier et al. · Nutrients · 2022 · 26 citations · Full text

Duodenal intraepithelial lymphocytosis is common in children without coeliac disease, and is not meaningfully influenced by <i>Helicobacter pylori</i> infection

Anat Guz‐Mark, Noam Zevit, Sara Morgenstern et al. · Alimentary Pharmacology & Therapeutics · 2014 · 24 citations · Full text